HPV-Mediated (p16+) Oropharyngeal Cancer (Clinical)

cTNM Staging | AJCC 2017

HPV-Mediated (p16+) Oropharyngeal Cancer (Clinical)

cTNM Staging | AJCC 2017

HPV-Mediated (p16+) Oropharyngeal Cancer (Clinical)

cTNM Staging | AJCC 2017

HPV-Mediated (p16+) Oropharyngeal Cancer (Clinical)

cTNM Staging | AJCC 2017

1.Primary Tumour (T)
2.Regional Lymph Nodes (cN)
3.Distant Metastasis (M)
Created by on 09/01/2016

By using this site you acknowledge that you have read, understand, and agree to be bound by our terms of use and privacy policy. All content and tools are for educational use only, are not meant to be a substitute for professional advice and should not be used for medical diagnosis and/or medical treatment.

About this Calculator

The TNM staging system anatomically classifies malignancies based on the extent of the primary tumour, regional lymph node involvement, and distant metastases. Staging helps physicians decide eligibility for clinical trials, define a patient's prognosis, and determine best treatment options.

The American Joint Committee on Cancer (AJCC) publishes the AJCC Cancer Staging Manual every 6-8 years. This tool is based on the 8th edition (2017) which represents the most up to date TNM staging guide.

References

AJCC Cancer Staging Manual.

American Joint Committee on Cancer (AJCC). 8th edition. New York: Springer; 2017.

The HPV-Mediated (p16+) Oropharyngeal Cancer (Clinical) calculator is created by QxMD.

1. Primary Tumour (T)

More Information

*Mucosal extension to lingual surface of epiglottis from primary tumours of the base of the tongue and vallecula does not constitute invasion of the larynx

Created by on 09/01/2016

By using this site you acknowledge that you have read, understand, and agree to be bound by our terms of use and privacy policy. All content and tools are for educational use only, are not meant to be a substitute for professional advice and should not be used for medical diagnosis and/or medical treatment.

0/3 completed